×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)

Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)

货号:CL-0326

规格:1×10⁶cells/T25培养瓶

价格: ¥1400

生长培养基:McCoy's 5A10% FBS1% P/S

数量: - +

  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
  • Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)

推荐搭配

套餐1:

Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确) ¥1400
Caki-2细胞专用培养基
  • ¥350
  • ¥500

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1750¥1900

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 Caki-2 (人乳头状肾细胞癌细胞)(STR鉴定正确)
别称 CAKI-2; CaKi-2; caki-2; CAKI 2; Caki 2; Caki2; CAKI2
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 Caki-2细胞源自一位69岁白人男性的初期肾腺癌组织。
年龄(性别) 男性;69岁
组织来源 肾脏
细胞类型 肿瘤细胞
肿瘤类型 肾癌细胞
生物安全等级 BSL-1
倍增时间 ~30-40 hours
致瘤性 Yes, in nude mice; forms clear cell carcinoma.
抗原表达情况 Blood Type A; Rh-
保藏机构 ATCC; HTB-47 DSMZ; ACC-54 ECACC; 93120819
STR鉴定
  • STR位点信息
    Amelogenin X,Y
    CSF1PO 10,12
    D2S1338 17,20
    D3S1358 14
    D5S818 11
    D7S820 12
    D8S1179 10
    D13S317 10
    D16S539 9,13
    D18S51 17
    D19S433 13,14
    D21S11 27,31
    FGA 21,22
    PentaD 10,13
    PentaE 7,17
    TH01 6
    TPOX 9,11
    vWA 16,17
    D6S1043 11,17
    D12S391 19,23
    D2S441 14
  • STR鉴定图
参考文献
文献列表
  • Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma (2023-03-02)

    作者:Zhenyuan Yu:1.Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China. ; 2.Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China. ; Yufang Lv:1.Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, P.R. China. ; 2.Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P.R. China. ; Cheng Su:1.Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi

    期刊:Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma

    DOI:10.1158/0008-5472.CAN-22-2224

    影响因子 :11.2

    引用产品: 786-O [786-0] 细胞 ,  Caki-2 细胞 ,  McCoy's 5A (含双抗) 培养基

  • ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma (2023-04-24)

    作者:Huihui Yang:1.Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing100069, China. ; Hongning Zhang:1.Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing100069, China. ; Liuxu Zhang:1.Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing100069, China. ; Paizigul Tusuphan:1.Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing100069, China. ; Junfang Zheng:1.Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing100069

    期刊:ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma

    DOI:10.3390/ijms24097755

    影响因子 :5.6

    引用产品: Caki-2 细胞

  • Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing (2023-07-29)

    作者:Zhen Zhang:1.Department of Anesthesiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. Electronic address: zlyyzhangzhen2130@zzu.edu.cn. ; Chunhua Cao:1.Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China; Institute of Oncology, Hubei University of Arts and Science, Xiangyang 441021, China. ; Chun-Li Zhou:1.Department of Anesthesiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, China. ; Xilong Li:1.Department of Anesthesiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. ; Changhong Miao:1.Department of Anesthesiology, Cancer Hospital of Fudan University, Shanghai 200032, China. ; Li Shen:1.Department of Biomedical Engineering, Hong Kong Polytechnic University, Hong Kong SAR, China. ; Rajeev K Singla:1.Joint Labo

    期刊:Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing

    DOI:10.1016/j.tranon.2023.101741

    影响因子 :5.0

    引用产品: HK-2 细胞 ,  Caki-2 细胞

  • Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1 (2023-05-29)

    作者:Lin Yang:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Jiahao Liu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Sheng Li:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Xiaoqiang Liu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Fuchun Zheng:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Songhui Xu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Bin Fu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. urofbin@163.com. ; Jing Xiong:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. alex7023@126.com. ;

    期刊:Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1

    DOI:10.1007/s00432-023-04877-x

    影响因子 :3.6

    引用产品: HK-2 细胞 ,  Caki-1 细胞 ,  OS-RC-2 细胞

  • Long noncoding RNA-LINC00478 promotes the progression of clear cell renal cell carcinoma through PBX3 (2022-09-09)

    作者:Zhiling Tang:1.Department of Urology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. ; Chenye Tang:1.Department of Urology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. ; Chun Sun:1.Department of Urology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. ; Xiangjun Ying:1.Department of Urology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. ; Ruilin Shen:1.Department of Urology Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China. ;

    期刊:Long noncoding RNA-LINC00478 promotes the progression of clear cell renal cell carcinoma through PBX3

    DOI:10.1002/jbt.23214

    影响因子 :3.6

    引用产品: Caki-2 细胞

  • Epigenetic inactivation of hydroxymethylglutaryl CoA synthase reduces ketogenesis and facilitates tumor cell motility in clear cell renal carcinoma (2009-01-20)

    作者:Peipei Han:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China; Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China. ; Yifang Wang:1.Life Science Institute, Guangxi Medical University, Nanning, China. ; Wenqi Luo:1.Department of Pathology, Guangxi Medical University Cancer Hospital, Nanning, China. ; Yunliang Lu:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Xiaohui Zhou:1.Life Science Institute, Guangxi Medical University, Nanning, China. ; Yanping Yang:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Qian Zheng:1.Life Science Institute, Guangxi Medical University, Nanning, China. ; Danping Li:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University)

    期刊:Epigenetic inactivation of hydroxymethylglutaryl CoA synthase reduces ketogenesis and facilitates tumor cell motility in clear cell renal carcinoma

    DOI:10.1016/j.prp.2021.153622

    影响因子 :3.3

    引用产品: A-498 细胞 ,  Caki-2 细胞

  • Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis (2001-01-20)

    作者:Fanchang Zeng:1.Department of Urology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, P.R. China. ; Liumei Luo:1.Division of Science and Education, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, P.R. China. ; Mi Song:1.Department of Urology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, P.R. China. ; Daoyuan Li:1.Department of Urology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Hainan, P.R. China. ;

    期刊:Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis

    DOI:10.1080/10799893.2020.1870494

    影响因子 :2.8

    引用产品: Caki-2 细胞 ,  786-O [786-0] 细胞

  • Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55 (2012-00-20)

    作者:Jiafu Feng:1.Department of Clinical Laboratory, Mianyang Central Hospital, No. 12, Changjia Lane, Jingzhong Street, Fucheng District, Sichuan Province, 621000, Mianyang, PR China. jiafufeng@aliyun.com. ; Yongcan Guo:1.Clinical Laboratory of Traditional, Chinese Medicine Hospital Affiliated to Southwest Medical University, 646000, Luzhou, Province, PR China. ; Yuanmeng Li:1.Department of Medical Laboratory, Affiliated Hospital of Southwest Medical University, Sichuan Province, 646000, Luzhou, PR China. ; Jiawei Zeng:1.Department of Clinical Laboratory, Mianyang Central Hospital, No. 12, Changjia Lane, Jingzhong Street, Fucheng District, Sichuan Province, 621000, Mianyang, PR China. ; Yaodong Wang:1.Department of Urology Surgery, Mianyang Central Hospital, Sichuan Province, 621000, Mianyang, PR China. ; Yuwei Yang:1.Department of Clinical Laboratory, Mianyang Central Hospital, No. 12, Changjia Lane, Jingzhong Street, Fucheng District, Sichuan Province, 621000, Mianyang, PR China. ;

    期刊:Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55

    DOI:10.1186/s13046-020-01744-2

    影响因子 :11.3

    引用产品: A-498 细胞 ,  Caki-1 细胞 ,  Caki-2 细胞 ,  786-O [786-0] 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号